{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"Kelch-11: Divyanshu (Div) Dubey, M.B.B.S.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/cb6d3281\"></iframe>","width":"100%","height":180,"duration":1152,"description":"Div Dubey, M.B.B.S., explains Mayo Clinic Laboratories' new testing approach for Kelch-11 antibodies, which are a protein biomarker for testicular cancer-associated paraneoplastic encephalitis. The pioneering test, which is the world’s first, screens patients for Kelch-11 proteins through a mechanized cell-based assay that utilizes cutting-edge, slide-scanner technology, and then employs tissue immunofluorescence to confirm presence of the protein. Early detection and treatment increase patient response to therapy and can sometimes enable a return to normal function. ","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}